STAT+: Pfizer faces criticism for arguing that intellectual property for its Covid-19 pill is a human right

“Using the claim of a human rights violation to prevent equitable access to its Covid medicines is neither ethical nor responsible."

Numerous advocacy groups and institutional shareholders are chiding Pfizer for arguing that its intellectual property is a human right and would be violated if the Dominican Republican government issues a compulsory license for its Covid-19 pill.

Advocates say the company invoked human rights in a recent hearing in which it attempted to convince the Dominican government not to issue such a license for its pill, Paxlovid. A petition to issue a license was filed in December after the country was excluded from a licensing deal to make the medicine available in mostly poor countries. A decision could come by next week.

Continue to STAT+ to read the full story…